
Mariam Ileyemi
Development Journalist at Premium Times
Mrs A || Health & Development Journalist @PremiumTimesng || Media-EIS Fellow || Inequality Reporting Fellow 2022 @Dev_journalism | 📧[email protected]
Articles
-
4 days ago |
premiumtimesng.com | Mariam Ileyemi
The Nigerian Institute of Medical Research(NIMR) has conducted a mass drug administration of Azithromycin to “over four million children” in the country, as part of a major study aimed at tackling child mortality. The study, known as Safety and Antimicrobial Resistance of Mass Administration of Azithromycin in Nigeria (SARMAAN), targets children aged one to 11 months in communities with high infant mortality rates.
-
4 days ago |
premiumtimesng.com | Mariam Ileyemi
The Nigerian Institute of Medical Research (NIMR) has raised concerns over the reliability of Nigeria’s current maternal mortality statistics, questioning how such data is obtained without adequate post-mortem investigations.
-
4 days ago |
premiumtimesng.com | Mariam Ileyemi |Fortune Eromonsele
Two years into President Bola Tinubu’s tenure, Nigeria’s health sector remains fragile, swamped with various interventions, yet still burdened by old challenges. Despite campaign promises of reforms and some execution, the country continues to grapple with underfunding, inadequate infrastructure, workforce shortages, recurring disease outbreaks, electricity crises in hospitals, and limited access to healthcare services.
-
4 days ago |
htsyndication.com | Mariam Ileyemi |Fortune Eromonsele
Nigeria, June 4 -- Two years into President Bola Tinubu's tenure, Nigeria's health sector remains fragile, swamped with various interventions, yet still burdened by old challenges. Despite campaign promises of reforms and some execution, the country continues to grapple with underfunding, inadequate infrastructure, workforce shortages, recurring disease outbreaks, electricity crises in hospitals, and limited access to healthcare services.
-
4 days ago |
htsyndication.com | Mariam Ileyemi
Nigeria, June 4 -- The Nigerian Institute of Medical Research(NIMR) has conducted a mass drug administration of Azithromycin to "over four million children" in the country, as part of a major study aimed at tackling child mortality. The study, known as Safety and Antimicrobial Resistance of Mass Administration of Azithromycin in Nigeria (SARMAAN), targets children aged one to 11 months in communities with high infant mortality rates.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 4K
- DMs Open
- Yes

RT @TheICIR: 💊 Drug resistance is a growing threat in Nigeria! When medicines stop working, infections become harder to treat-often due to…

RT @Omojuwa: I am in awe. Several weeks ago, I touched this God’s beautiful gift. I am still ensconced in the reverie. Left in awe of the…

RT @Omojuwa: https://t.co/kgcd0ghcuO